Comorbidities and mortality rate in COVID-19 patients with hematological malignancies: A systematic review and meta-analysis.

Adel NaimiIlya YashmiReza JebelehMohammad Imani MofradShakiba Azimian AbharYasaman JannesarMohsen HeidaryReza Pakzad

Published in: Journal of clinical laboratory analysis (2022)

This study demonstrated that hematologic cancer patients were more susceptible to a severe COVID-19 than patients without blood cancer. Thus, the management of COVID-19 in these patients requires much more attention, and their screening should perform regularly.

Keyphrases

end stage renal disease
sars cov
coronavirus disease
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
peritoneal dialysis
cardiovascular disease
early onset
risk factors
respiratory syndrome coronavirus
drug induced